About Atorvia Health

Atorvia is a pre-clinical biotech company focused on kidney failure by developing engineered peptide therapeutics that inhibit protein-protein interactions leading to cell death. Their research identifies structural changes in stressed cells, enabling new diagnostic and therapeutic strategies for kidney disease.

```xml <problem> Kidney failure affects millions, often requiring dialysis and leading to complications like heart disease and diabetes, yet effective treatment options remain limited. Current diagnostic methods may not detect early structural changes in stressed kidney cells, hindering timely intervention. </problem> <solution> Atorvia is developing engineered peptide therapeutics designed to inhibit protein-protein interactions that lead to cell death in kidney failure. By targeting structural changes in stressed kidney cells, Atorvia's research aims to create new diagnostic and therapeutic strategies for kidney disease. Their novel peptide therapeutic is designed to address kidney failure, offering a potential treatment option for patients who currently lack alternatives. This approach seeks to prevent the need for dialysis and reduce the long-term health complications associated with kidney failure. </solution> <features> - Engineered peptide therapeutics targeting protein-protein interactions - Focus on inhibiting cell death pathways in kidney cells - Research-driven approach to identify structural changes in stressed cells - Development of novel diagnostic strategies for early detection of kidney disease </features> <target_audience> The primary target audience includes patients at risk of or suffering from kidney failure, as well as healthcare providers and researchers focused on kidney disease treatment and diagnostics. </target_audience> ```

What does Atorvia Health do?

Where is Atorvia Health located?

Atorvia Health is based in San Francisco, United States.

When was Atorvia Health founded?

Atorvia Health was founded in 2021.

How much funding has Atorvia Health raised?

Atorvia Health has raised 5900.

Location

San Francisco, United States

Founded

2021

Funding

5900

Employees

5 employees

Find Investable Startups and Competitors

Search thousands of startups using natural language

AI voice (2021+)underground pipe robots energy flexibility software

Start Searching

Atorvia Health

⚠️ AI-generated overview based on web search data – may contain errors, please verify information yourself! You can claim this account with your email domain to make edits.

Executive Summary

atorvia.co 500+

Crunchbase

Founded 2021 – San Francisco, United States

Funding

Estimated Funding

Team (5+)

No team information available.

Company Description

Problem

Kidney failure affects millions, often requiring dialysis and leading to complications like heart disease and diabetes, yet effective treatment options remain limited. Current diagnostic methods may not detect early structural changes in stressed kidney cells, hindering timely intervention.

Solution

Atorvia is developing engineered peptide therapeutics designed to inhibit protein-protein interactions that lead to cell death in kidney failure. By targeting structural changes in stressed kidney cells, Atorvia's research aims to create new diagnostic and therapeutic strategies for kidney disease. Their novel peptide therapeutic is designed to address kidney failure, offering a potential treatment option for patients who currently lack alternatives. This approach seeks to prevent the need for dialysis and reduce the long-term health complications associated with kidney failure.

Features

Engineered peptide therapeutics targeting protein-protein interactions

Focus on inhibiting cell death pathways in kidney cells

Research-driven approach to identify structural changes in stressed cells

Development of novel diagnostic strategies for early detection of kidney disease

Target Audience

The primary target audience includes patients at risk of or suffering from kidney failure, as well as healthcare providers and researchers focused on kidney disease treatment and diagnostics.